منابع مشابه
Treatment of Opioid Addiction
The College in New Brunswick was reluctant to arbitrarily select one approach over the other, even granting the similarities. It was felt appropriate to allow physicians to adopt one of these established approaches to guide them. They could then modify their approach as they gain experience. That said, for the sake of some consistency, the College can point to the most recent guidelines from No...
متن کاملHepatitis in Opioid Addiction Treatment
Links: [1] https://www.buppractice.com/node/103 [2] http://dpt.samhsa.gov/pdf/HepC_draft_monograph_5-8-2006.pdf [3] https://www.buppractice.com/taxonomy/term/28 [4] https://www.buppractice.com/taxonomy/term/116 [5] https://www.buppractice.com/taxonomy/term/50 [6] https://www.buppractice.com/taxonomy/term/52 [7] https://www.buppractice.com/taxonomy/term/61 [8] https://www.buppractice.com/taxonom...
متن کاملOpioid dependence and addiction during opioid treatment of chronic pain.
Throughout the long history of opioid drug use by humans, it has been known that opioids are powerful analgesics, but they can cause addiction. It has also been observed, and is now substantiated by multiple reports and studies, that during opioid treatment of severe and short-term pain, addiction arises only rarely. However, when opioids are extended to patients with chronic pain, and therapeu...
متن کاملUse and misuse of opioid agonists in opioid addiction.
Although methadone (an opioid agonist) and buprenorphine (a partial opioid agonist) have evidence to support their use in treating opioid use disorder, they remain misunderstood and underutilized. In this article, we outline the risks and benefits of using these drugs as maintenance therapy in opioid-dependent patients.
متن کاملOpioid pharmacogenetics of alcohol addiction.
Alcohol addiction is one of the most common and devastating diseases in the world. Given the tremendous heterogeneity of alcohol-addicted individuals, it is unlikely that one medication will help nearly all patients. Thus, there is a clear need to develop predictors of response to existing medications. Naltrexone is a μ-opioid receptor antagonist, which has been approved in the United States fo...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Australian Prescriber
سال: 2013
ISSN: 0312-8008,1839-3942
DOI: 10.18773/austprescr.2013.033